Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine,
Modified Live Virus
Canine distemper, adenovirus type 2, parainfluenza, and parvovirus
vaccine, modified live virus.
Contains gentamicin as a preservative.
DA2PPv is for the vaccination of healthy dogs against disease caused by
canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type
2 (respiratory disease), canine parainfluenza virus, and canine
Dosage and Administration:
Inject one dose (1 mL) subcutaneously or
intramuscularly. The initial dose may be given at 6 weeks of age or
older. Repeat at 2 to 4 week intervals until the dog is 12 weeks of
age. A minimum of two doses is required for primary immunization.
Annual revaccination with one dose is recommended.
Transfer contents of the sterile diluent vial to the
vial aseptically. Mix gently until dissolved. Use entire
contents immediately after rehydration.
Do not vaccinate pregnant bitches.
Store between 2° and 7°C. Do not
Use new, non-chemically sterilized, needles and syringes.
Do not mix with other vaccines.
Burn vaccine container and all unused contents.
Vaccinate only healthy, non-parasitized dogs.
The use of a biological product may product
anaphylaxis and/or other inflammatory immune-mediated hypersensitivity
The age at which maternal antibodies for canine
parvovirus no longer interferes with the development of active immunity
and varies according to the bitch's titer and quantity of colostral
antibodies absorbed by the puppy.
Epinephrine, corticosteroids, and antihistamines may all be indicated
depending on the nature and severity of the reaction.
For veterinary use only. For use in dogs only.
Data indicate the development of corneal opacity is not associated with
the use of this product.